Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
117.40   -1.52 (1.28%)  114.06 - 121.12  165,700

Overview

 
Avg Volume (4 weeks):267,070
4 Weeks Range:98.81 - 125.295
4 Weeks Price Volatility (%):
70.19%
52 Weeks Range:13.089 - 154.75
52 Weeks Price Volatility (%):
73.63%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

2972  4622  911  76 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EEM 46.88-0.38 
 GE 14.52-0.02 
 MDR 7.00+0.95 
 SPY 266.57-0.04 
 NVCN 0.05+0.001 
 BAC 30.32+0.06 
 XLF 27.85-0.03 
 MU 49.02-1.60 
 AMD 10.04+0.05 
 GDX 22.41-0.30 
Partners & Brokers